George Kollias Research Group

Agency:
European Research Council
Grant ID:
ERC-2021-AdG-101055093
Duration:
2022-2027
Type:
Advanced Grant
Title:
Contextual specification of fibroblast-driven causalities in chronic intestinal inflammation and fibrosis (BecomingCausal)
Budget:
2,411,000.00 €
PI:
George Kollias

Agency:
Hellenic Foundation for Research & Innovation (HFRI) ELIDEK
Grant ID:
3780
Duration:
2021-2024
Type:
1st Call for H.F.R.I. Research Projects to Support Faculty Members & Researchers and Procure High-Value Research Equipment
Title:
Understanding the heterogeneity of the tumor microenvironment at the single cell level/ SingleOut
Budget:
1,440,000.00 €
PI:
George Kollias

Agency:
NSRF 2014-2020, European Regional Development Fund, Operational Programme “Competitiveness, Entrepreneurship and Innovation 2014-2020 (EPAnEK)”
Grant ID:
MIS 5067529 / Τ2ΕΔΚ-01076
Duration:
2020-2023
Type:
GSRT Αction (ΕΡΕΥΝΩ-ΔΗΜΙΟΥΡΓΩ-ΚΑΙΝΟΤΟΜΩ)
Title:
Development of small molecule inhibitors for the treatment of chronic inflammatory diseases, targeting the activation of pathogenic fibroblasts- DrugARΤ
Budget:
996.550,30€ (Total) / 672.300,07€ 98 (Fleming)
PI:
George Kollias
URL:
https://bsrcfleming.wixsite.com/drugart

Agency:
European Commission - Horizon 2020
Grant ID:
730879
Duration:
2017-2020
Type:
H2020-INFRADEV-2016-1
Title:
Towards enduring mouse resources and services advancing research into human health and disease – INFRAFRONTIER2020
Budget:
107,800.00 €
URL:
http://www.infrafrontier.eu

Agency:
NSRF2014-2020, European Regional Development Fund
Grant ID:
5002135
Duration:
2017-2020
Type:
Reinforcement of the Research and Innovation Infrastructure
Title:
InfrafrontierGR/Phenotypos: The Greek Research Infrastructure for Molecular and Behavioural Phenotyping of biological model organisms for chronic degenerative diseases
Budget:
2,950,000.00 €
URL:
http://www.infrafrontier.gr

Agency:
STAVROS NIARCHOS FOUNDATION
Duration:
2016-2019
Type:
Donation
Title:
Support and Development of BSRC “Alexander Fleming”

Agency:
NSRF2014-2020, European Regional Development Fund
Grant ID:
5002802
Duration:
2017-2020
Type:
Reinforcement of the Research and Innovation Infrastructure
Title:
The Greek Research Infrastructure for Personalised Medicine (pMedGR)
Budget:
650,000.00 €
URL:
https://www.precisionmedicine.gr

Agency:
European Research Council (ERC-2013-AdG-340217)
Duration:
2014-2019
Type:
Advanced Grant
Title:
Mesenchymal Cells of the Lamina Propria in Intestinal Epithelial and Immunological Homeostasis (MCs-inTEST)
Budget:
2,590,000.00 €

Agency:
European Commission FP, Grant agreement No 312325.
Duration:
2012-2015
Type:
Combination of Collaborative Projects and Coordination and Support Actions
Title:
Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation (INFRAFRONTIER-I3)
URL:
http://www.infrafrontier.eu

Agency:
Ministry of Development, ΟΠΣ 423575.
Duration:
2012-2015
Type:
Infrafrontier ATTICA - Support and development of Greek partners for participation in Consortia of European Research Infrastructures in the context of ESFRI 2006
Title:
The Greek Research Infrastructure for phenotyping and archiving of model mammalian genomes (INFRAFRONTIER-GR)
URL:
https://www.infrafrontier.gr/

Agency:
General Secretariat for Research and Technology – ERC-06
Duration:
2012-2015
Type:
Funding for proposals positively evaluated in the 3rd and 4th FP7 ERC Calls
Title:
Innate activation of the Synovial Fibroblasts and early causalities driving chronic arthritis (ΙΝΝΑΤΕ FIBROBLAST)

Agency:
The Danish Council for Strategic research – 11-115321
Duration:
2012-2015
Type:
Strategic Research Project
Title:
Non-invasive nanoparticle delivery of nucleic acid therapeutics across biological barriers (Nanobar)

Agency:
European Commision HEALTH.2011.1.4-3, SADEL
Duration:
2011-2016
Type:
FP7 SME-targeted Collaborative Project
Title:
Scaffolds for alternative delivery
URL:
http://www.sadelproject.eu

Agency:
Innovative Medicines Initiative Joint Undertaking (IMI JU)/ No.115142-2
Grant ID:
115142-2
Duration:
2011-2015
Type:
IMI Call topic: Inflammation – Translational Research and Adaptive Immunity
Title:
BeTheCure (BTCURE)
Budget:
1,074,200.00 €
URL:
http://btcure.eu/

Agency:
General Secreteriat for Research and Technology 09ΣΥΝ-21-784
Duration:
2011-2014
Type:
SYNERGASIA action
Title:
From Targets to Leads: Innovative therapeutics for Arthritis (TheRAlead)
URL:
http://bsrcfleming.wix.com/theralead

Agency:
General Secreteriat for Research and Technology 5398/31.03.2009
Duration:
2010-2011
Type:
Establishment of National Research Infrastructures in areas relating to the roadmap for ESFRI Infrastructures
Title:
The Greek Research Infrastructure for phenotyping and archiving of model mammalian genomes (INFRAFRONTIER-GR)
URL:
http://www.infrafrontier.eu/

Agency:
INFRAFRONTIER No 211404, CP-CSA_INFRA-2007-2.2.01
Duration:
2008-2011
Type:
Combination of Collaborative Project and Coordination and Support Actions
Title:
The European infrastructure for phenotyping and archiving of model mammalian genomes
URL:
http://www.infrafrontier.eu/

Agency:
MASTERSWITCH HEALTH-F2-2008-223404
Duration:
2008-2013
Type:
Large scale integrating project
Title:
Mechanisms to Attack Steering Effectors of Rheumatoid Syndromes with Innovative Therapy Choices
URL:
http://www.masterswitchproject.eu/

Agency:
INFLACARE HEALTH-F2-2009-223151
Duration:
2009-2012
Type:
Large scale integrating project
Title:
Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies
URL:
http://inflacare.imbb.forth.gr/

Agency:
LSHG-CT-2006-037188
Duration:
2007-2011
Type:
Life Sciences, Genomics and Biotechnology for Health
Title:
The European Mouse Disease Clinic: A distributed phenotyping resource for studying human disease (EUMODIC)
URL:
http://www.eumodic.org/

Agency:
European Commission LSHG-CT-2006-037811
Duration:
2007-2009
Type:
Co-ordination action (7 participating labs)
Title:
Coordination and Sustainability of International Mouse Informatics Resources (CASIMIR)
URL:
http://www.casimir.org.uk/

Agency:
European Commission – 028190
Duration:
2006-2009
Type:
Integrating and strengthening the European Research Area
Title:
TNF neutralization therapy for inflammatory diseases strategies to prevent TB reactivation (TB REACT)
URL:
http://www.cnrs-orleans.fr/iem/tbreact/

Agency:
European Commission NoE – LSHG-CT-2005-005203
Duration:
2005-2009
Type:
Network of Excellence (24 participating labs)
Title:
Integrated functional genomics in mutant mouse models as tools to investigate the complexity of human immunological disease (MUGEN)
URL:
http://www.mugen-noe.org/

Agency:
European Commission – LSHB-CT-2004-005276
Duration:
2005-2009
Type:
Sixth Framework Programme for Research and Development (FP6)
Title:
Right Interference Technology as Human Therapeutic Tool (RIGHT)
URL:
http://www.ip-right.org/

Agency:
Hellenic Ministry for Development – ΕΠΑΝ 340
Duration:
2005-2008
Type:
Excellence in the Research Institutes
Title:
Research infrastructures of the Institute of Immunology of the BSRC Fleming

Agency:
Hellenic Ministry for Development – 04ΑΚΜΩΝ72
Duration:
2005-2008
Type:
AKMON
Title:
Enhancement of services in transgenesis, on disease models and macromolecular analysis from laboratories of the BSRC Fleming

Agency:
Hellenic Ministry for Development GSRT-PENED-03ΕΔ770
Duration:
2005-2008
Type:
Locan Education (PhD) grant
Title:
Detection and genetic modification of pathogenic intracellular signaling pathways in chronic inflammatory bowel disease

Agency:
European Commission – MRTN-CT-2004-005693
Duration:
2004-2008
Type:
Marie Curie Research Training Network (10 participating labs)
Title:
Functional Genomic Approaches Targeting Arthritis
URL:
http://www.euro-ra.de/

Agency:
Hellenic Ministry for Development – 04ΔΙΑΜ08
Duration:
2005-2007
Type:
Creation and Support of Technology Transfer Offices
Title:
Creation and Support of Technology Transfer Offices of the BSRC Fleming

Agency:
Hellenic Ministry for Development – 05ΕΑΘ-10
Duration:
2005-2007
Type:
Open Gates Program
Title:
Sensitization of the Public to New Research Technologies